ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1231

Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS

Jorge Juan Fragio Gil1, Roxana Gonzalez Mazario1, Francisco Miguel Ortiz-Sanjuán1, Jose Ivorra Cortes1, Elena Grau Garcia1, Karla Arevalo1, Isabel Martinez Cordellat1, Inmaculada Chalmeta Verdejo1, Jose Eloy Oller Rodriguez1, Luis Gonzalez Puig1, Marta De la Rubia Navarro1, Rosa Negueroles Albuixech1, Cristina Alcañiz Escandell2, Elvira Vicens Bernabeu1, Eva Calabuig3, Maria Tasias Pitarch3, Miguel Salavert Lleti3 and Jose Andres Roman Ivorra1, 1Rheumatology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, 2IIS La Fe, Valencia, Spain, 3Infectious Diseases Unit. Hospital Universitario y Politecnico La Fe, Valencia, Spain

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Back pain, Infection, osteomyelitis and spine involvement

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Infection-related Rheumatic Disease Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Vertebral Osteomyelitis is an infectious disease of the vertebral body which could involve the intervertebral space (spondylodiscitis). Early diagnosis and treatment are essential in order to achieve the best chance of a good outcome, but these are often delayed because it tends to present nonspecific manifestations. Our purpose was to identify risk factors and outcome variables in our cohort.

Methods: Single center longitudinal retrospective observational study including patients diagnosed of Vertebral Osteomyelitis from January 2010 to March 2018. Demographic, clinical, microbiology and radiological data were compiled. Long hospital stay, readmission, vertebral destruction, neurological damage and death were chosen as outcome variables. Patients aging under 18 were excluded. The statistical analysis was performed with the software R, version 3.3.2.

Results: 116 patients were included, with a mean age of 62.05 (16.94) years old. Male sex accounted 68.10%. 58.62% had medical history of spine pathology. 18 patients (15.51%) presented immunosuppression (rheumatic or inflammatory bowel disease on treament, malignancy, HIV or solid organ transplantation). Most frequent symptom was back pain (99.14%), fever was only in 45 patients (38.79%). Acute paraparesis was presented in 21 patients (19.10%) at diagnosis. Mean diagnosis deay was 54.14 days. 14 patients had underlying endocarditis (12.07%). Most of patients (94.83%) showed high CRP levels at diagnosis, with an average value of 103.47 mg/L, which was not related to worse outcome. Mean length of hospital stay was 34.24 (34.3) days and readmission rate was 34.9%. Blood cultures were positive in 46 patients (39.66%). Punction-aspiration was performed in 84 patients (72.10%) and its culture were positive in 48 samples (57.14%). Median delay from suspicion to biopsy was 6 days. Gram positive predominated (73.86%), followed by Gram negative species (12.5%), mycobacteria (10.23%) and fungi (3.41%). No microorganism was identified in 28 patients (24.14%). On imaging, most of the patients (92.24%) had paravertebral or epidural abscess. 63 cases (54.31%) showed vertebral destruction and 39 (33.62%) cord compression. Vertebral destruction was related to epidural abscess (p=0.006). 22 patients (18.97%) required further surgical procedures. Age trend to be related to worse outcome with no statistical signification. Diabetes mellitus was associated to greater vertebral destruction (p=0.01) and cord compression (p=0.02). Longer pain duration correlated with neurological damage (p=0.02). Underlying infectious endocarditis patients showed higher vertebral destruction (p=0.01). 11 patients (9.48%) died during follow-up.

Conclusion: Delay in diagnosis is still an important issue that is associated to higher complication rates, mainly related to structural damage of the spine. It has been also found that the presence of an epidural vertebral abscess is related to greater vertebral destruction. Elderly, diabetic and immunosuppressed patients had the worse chance of a good outcome, so these patients should be more careful managed (always try to obtain an imaging-guided biopsy, correct antibiotic treatment, and a functional and clinical follow-up).


Disclosure: J. J. Fragio Gil, None; R. Gonzalez Mazario, None; F. M. Ortiz-Sanjuán, None; J. Ivorra Cortes, None; E. Grau Garcia, None; K. Arevalo, None; I. Martinez Cordellat, None; I. Chalmeta Verdejo, None; J. E. Oller Rodriguez, None; L. Gonzalez Puig, None; M. De la Rubia Navarro, None; R. Negueroles Albuixech, None; C. Alcañiz Escandell, None; E. Vicens Bernabeu, None; E. Calabuig, None; M. Tasias Pitarch, None; M. Salavert Lleti, None; J. A. Roman Ivorra, None.

To cite this abstract in AMA style:

Fragio Gil JJ, Gonzalez Mazario R, Ortiz-Sanjuán FM, Ivorra Cortes J, Grau Garcia E, Arevalo K, Martinez Cordellat I, Chalmeta Verdejo I, Oller Rodriguez JE, Gonzalez Puig L, De la Rubia Navarro M, Negueroles Albuixech R, Alcañiz Escandell C, Vicens Bernabeu E, Calabuig E, Tasias Pitarch M, Salavert Lleti M, Roman Ivorra JA. Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/pyogenic-vertebral-osteomyelitis-outcome-variables-analysis-in-a-116-patients-cohort-at-a-tertiary-hospital-during-the-last-8-years/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pyogenic-vertebral-osteomyelitis-outcome-variables-analysis-in-a-116-patients-cohort-at-a-tertiary-hospital-during-the-last-8-years/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology